Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.

[1]  S. Uemoto,et al.  Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. , 2016, Nutrition.

[2]  S. Ichiyama,et al.  Bundled strategies against infection after liver transplantation: Lessons from multidrug‐resistant Pseudomonas aeruginosa , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  K. Fukumitsu.  Validation of Steroid-Free Immunosuppression Regimen after Liver Transplantation , 2015 .

[4]  Nobuya Inagaki,et al.  Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  A. Garber,et al.  Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation , 2014, Journal of gastroenterology and hepatology.

[6]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[7]  K Ogawa,et al.  Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  S. Yagi,et al.  Pre- and perioperative factors affecting infection after living donor liver transplantation. , 2012, Nutrition.

[9]  Douglas E Schaubel,et al.  Sarcopenia and mortality after liver transplantation. , 2010, Journal of the American College of Surgeons.

[10]  H. Ohdan,et al.  Current status of liver transplantation across ABO blood-type barrier. , 2008, Journal of hepato-biliary-pancreatic surgery.

[11]  H. Shimada,et al.  Outcomes of Adult-to-Adult Living Donor Liver Transplantation: A Single Institution's Experience With 335 Consecutive Cases , 2007, Annals of surgery.

[12]  M. Plauth,et al.  ESPEN Guidelines on Enteral Nutrition: Liver disease. , 2006, Clinical nutrition.

[13]  T. Kiuchi,et al.  SURGERY‐RELATED MORBIDITY IN LIVING DONORS OF RIGHT‐LOBE LIVER GRAFT: LESSONS FROM THE FIRST 200 CASES , 2003, Transplantation.

[14]  S. Streat,et al.  Sequential Changes in the Metabolic Response to Orthotopic Liver Transplantation During the First Year After Surgery , 2001, Annals of surgery.

[15]  S. Uemoto,et al.  Right lobe graft in living donor liver transplantation. , 1999, Transplantation.

[16]  Y. Yamaoka,et al.  The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. , 1996, Transplantation.

[17]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[18]  S. Fujita,et al.  RIGHT LOBE GRAFT IN LIVING DONOR LIVER TRANSPLANTATION 1,2 , 2000 .